343 related articles for article (PubMed ID: 28271209)
21. HDAC6 inhibitors sensitize non-mesenchymal triple-negative breast cancer cells to cysteine deprivation.
Alothaim T; Charbonneau M; Tang X
Sci Rep; 2021 May; 11(1):10956. PubMed ID: 34040090
[TBL] [Abstract][Full Text] [Related]
22. HDAC6 Promotes Cardiac Fibrosis Progression through Suppressing RASSF1A Expression.
Tao H; Yang JJ; Hu W; Shi KH; Li J
Cardiology; 2016; 133(1):18-26. PubMed ID: 26401643
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction.
Lam HC; Cloonan SM; Bhashyam AR; Haspel JA; Singh A; Sathirapongsasuti JF; Cervo M; Yao H; Chung AL; Mizumura K; An CH; Shan B; Franks JM; Haley KJ; Owen CA; Tesfaigzi Y; Washko GR; Quackenbush J; Silverman EK; Rahman I; Kim HP; Mahmood A; Biswal SS; Ryter SW; Choi AM
J Clin Invest; 2013 Dec; 123(12):5212-30. PubMed ID: 24200693
[TBL] [Abstract][Full Text] [Related]
24. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
Negmeldin AT; Knoff JR; Pflum MKH
Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
[TBL] [Abstract][Full Text] [Related]
25. Critical role of the HDAC6-cortactin axis in human megakaryocyte maturation leading to a proplatelet-formation defect.
Messaoudi K; Ali A; Ishaq R; Palazzo A; Sliwa D; Bluteau O; Souquère S; Muller D; Diop KM; Rameau P; Lapierre V; Marolleau JP; Matthias P; Godin I; Pierron G; Thomas SG; Watson SP; Droin N; Vainchenker W; Plo I; Raslova H; Debili N
Nat Commun; 2017 Nov; 8(1):1786. PubMed ID: 29176689
[TBL] [Abstract][Full Text] [Related]
26. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
27. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
[TBL] [Abstract][Full Text] [Related]
28. Akt activation is required for TGF-β1-induced osteoblast differentiation of MC3T3-E1 pre-osteoblasts.
Suzuki E; Ochiai-Shino H; Aoki H; Onodera S; Saito A; Saito A; Azuma T
PLoS One; 2014; 9(12):e112566. PubMed ID: 25470129
[TBL] [Abstract][Full Text] [Related]
29. Isolation of mesenchymal stem cells from human ligamentum flavum: implicating etiology of ligamentum flavum hypertrophy.
Chen YT; Wei JD; Wang JP; Lee HH; Chiang ER; Lai HC; Chen LL; Lee YT; Tsai CC; Liu CL; Hung SC
Spine (Phila Pa 1976); 2011 Aug; 36(18):E1193-200. PubMed ID: 21343850
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions.
Singhatanadgit W; Salih V; Olsen I
J Cell Physiol; 2006 Dec; 209(3):912-22. PubMed ID: 17001689
[TBL] [Abstract][Full Text] [Related]
31. Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion.
Zhu K; Zhang Y; Zhang J; Zhou F; Zhang L; Wang S; Zhu Q; Liu Q; Wang X; Zhou L
Toxicol Lett; 2020 Mar; 320():19-27. PubMed ID: 31778773
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).
Rimando MG; Wu HH; Liu YA; Lee CW; Kuo SW; Lo YP; Tseng KF; Liu YS; Lee OK
Sci Rep; 2016 Nov; 6():37371. PubMed ID: 27901049
[TBL] [Abstract][Full Text] [Related]
33. Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors.
Leonhardt M; Sellmer A; Krämer OH; Dove S; Elz S; Kraus B; Beyer M; Mahboobi S
Eur J Med Chem; 2018 May; 152():329-357. PubMed ID: 29738953
[TBL] [Abstract][Full Text] [Related]
34. HDAC6 inhibition suppresses chondrosarcoma by restoring the expression of primary cilia.
Xiang W; Guo F; Cheng W; Zhang J; Huang J; Wang R; Ma Z; Xu K
Oncol Rep; 2017 Jul; 38(1):229-236. PubMed ID: 28586053
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase 6 reduction promotes aortic valve calcification via an endoplasmic reticulum stress-mediated osteogenic pathway.
Fu Z; Li F; Jia L; Su S; Wang Y; Cai Z; Xiang M
J Thorac Cardiovasc Surg; 2019 Aug; 158(2):408-417.e2. PubMed ID: 30579537
[TBL] [Abstract][Full Text] [Related]
36. Lymphocyte chemotaxis is regulated by histone deacetylase 6, independently of its deacetylase activity.
Cabrero JR; Serrador JM; Barreiro O; Mittelbrunn M; Naranjo-Suárez S; Martín-Cófreces N; Vicente-Manzanares M; Mazitschek R; Bradner JE; Avila J; Valenzuela-Fernández A; Sánchez-Madrid F
Mol Biol Cell; 2006 Aug; 17(8):3435-45. PubMed ID: 16738306
[TBL] [Abstract][Full Text] [Related]
37. HDAC6 inhibition restores ciliary expression and decreases tumor growth.
Gradilone SA; Radtke BN; Bogert PS; Huang BQ; Gajdos GB; LaRusso NF
Cancer Res; 2013 Apr; 73(7):2259-70. PubMed ID: 23370327
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of histone deacetylase reduces lipopolysaccharide-induced-inflammation in primary mammary epithelial cells by regulating ROS-NF-кB signaling pathways.
Wang J; Zhao L; Wei Z; Zhang X; Wang Y; Li F; Fu Y; Liu B
Int Immunopharmacol; 2018 Mar; 56():230-234. PubMed ID: 29414656
[TBL] [Abstract][Full Text] [Related]
39. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
Beyer M; Kiweler N; Mahboobi S; Krämer OH
Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
[TBL] [Abstract][Full Text] [Related]
40. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
Laino AS; Betts BC; Veerapathran A; Dolgalev I; Sarnaik A; Quayle SN; Jones SS; Weber JS; Woods DM
J Immunother Cancer; 2019 Feb; 7(1):33. PubMed ID: 30728070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
